TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: Stipends Out For Trainees In new Clinical Program, But They Can Be Paid If Any Money Is Available May 31, 1974
TCL Archive In Brief: BCDDP “Dramatically” Changed U.S. Medical Practice, Fink Says; *% Not too uch-DeVita December 15, 1978
TCL Archive In Congress: Continuing Resolutions Keep Feds Running; Henney Nomination Stalled By Nickles October 16, 1998
